An interventional program to improve antibiotic use

Annals of Pharmacotherapy

Volumn 37, Issue 5, 2003, Pages 646-651

  Feucht, Cynthia L ^a   Rice, Louis B ^a,b,c  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Antibiotic resistance; Antibiotic utilization; Prescribing practice

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DRUG COST; DRUG UTILIZATION; GRAM NEGATIVE BACTERIUM; HEALTH PROGRAM; MEDICAL EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG COSTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; FLUOROQUINOLONES; HEALTH SERVICES MISUSE; HOSPITALS; HUMANS; PHYSICIANS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VANCOMYCIN;

EID: 0037406455     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C166     Document Type: Article

References (16)

1. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408-11.
2. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991;115:674-80.
3. Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 1997;5:180-8.
4. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
5. Gums J, Yancey R, Hamilton C, Kubilis P. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999;19:1369-77.
6. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90.
7. Lesar TS, Briceland LL. Survey of antibiotic control policies in university-affiliated teaching institutions. Ann Pharmacother 1996;30:31-4.
8. Rifenburg RP, Paladino JA, Hanson SC, Tuttle JA, Schentag JJ. Benchmark analysis of strategies hospitals use to control antimicrobial expenditures. Am J Health Syst Pharm 1996;53:2054-62.
9. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-40.
10. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987;82 (suppl 4A):391-4.
11. Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994;32:1757-62.
12. Berman J, Zaran F, Rybak M. Pharmacy-based antimicrobial-monitoring service. Am J Hosp Pharm 1992;49:1701-6.
13. Briceland L, Lesar T, Lomaestro B, Lombardi T, Gailey R, Kowalsky S. Streamlining antimicrobial therapy through pharmacists' review of order sheets. Am J Hosp Pharm 1989;46:1376-80.
14. Singh N, Rogers P, Atwood C, Wagener M, Yu V. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit, a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-11.
15. Recommendations for preventing the spread of vancomycin resistance: recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR Morb Mortal Wkly Rep 1994;44(RR-12).
16. Ryan F. The forgotten plague: how the battle against tuberculosis was won and lost. Boston: Little, Brown and Company, 1992:405-11.